… cancer patients treated with gemcitabine and bevacizumab. … patients early hypertension
defined as >grade 2 correlated … series of bevacizumab-treated colorectal cancer patients, …

… bevacizumab, we retrospectively analysed the correlation between the modifications of arterial
blood pressure … prolonged PFS in patients with mCRC receiving first-line bevacizumab. …

… hypertension in patients with metastatic colorectal cancer. … of bevacizumab-induced
hypertension with outcome in patients … As mentioned above, arterial hypertension is a common …

… correlated with response to treatment with bevacizumab in … in patients with advanced
colorectal cancer receiving first-line … The highest value of arterial blood pressure recorded was …

… Ten studies included patients treated with bevacizumab in the first line setting, whereas four
… the correlation between bevacizumab-induced HTN and survival outcomes in patients with …

… Arterial hypertension (AHT) is a common toxicity with bevacizumab (BVZ)-containing …
Once we could not correlate the AHT, with PFS to CT/BVZ, we evaluated several cut-offs of …

… ) as a first-line treatment for metastatic colorectal cancer (CRC). In 2006, the FDA approved
… determine whether there was any correlation between bevacizumab-induced HTN and OS. …

… the development of hypertension during treatment with bevacizumab has no independent
… treatment with bevacizumab, the cumulative dose, and the risk of experiencing hypertension…

… treatment-related HTN is associated with outcome and safety in 101 consecutive mCRC patients
treated with bevacizumab… For patients who received bevacizumab as part of the first-line …

… , may represent a clinical biomarker to predict the efficacy of the treatment. The aim of this …
2 to 4 were correlated with response to treatment with bevacizumab in first line, as well as with …